HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICCR Accepts Four Regulatory Guidance Reports; NGOs Seek Bigger Role

This article was originally published in The Rose Sheet

Executive Summary

Regulators from the U.S., Canada, the EU and Japan accepted reports offering guidelines for regulatory harmonization within the areas of nanotechnology, alternative test methods, trace materials and safety assessments at the fifth meeting of the International Cooperation on Cosmetic Regulation.

You may also be interested in...



ICCR Finalizing Nanotech, Trace Impurities Reports Following 6th Meeting

Regulators from the U.S., the EU, Canada and Japan are working to finalize reports on nanomaterials, trace impurities and animal testing alternatives following the sixth meeting of the International Cooperation on Cosmetics Regulation. The regulators came to agreements on the reports at the July 10-13 meeting in Rockville, Md., and will hammer out the details before releasing the reports this fall.

Nanomaterials Should Be Measured In Final Product Formulations – ICCR Report

FDA Eyes Industry-Proposed Lead Limit, With Lipstick Report Slated For Fall

FDA is expected to release a report detailing its findings on lead in lipstick this fall, but it remains to be seen whether the agency will heed industry requests to set a maximum limit for the trace contaminant in cosmetic products.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017683

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel